2-39023118-A-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_005633.4(SOS1):c.1310T>A(p.Ile437Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I437T) has been classified as Pathogenic.
Frequency
Consequence
NM_005633.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOS1 | NM_005633.4 | c.1310T>A | p.Ile437Asn | missense_variant | 10/23 | ENST00000402219.8 | NP_005624.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOS1 | ENST00000402219.8 | c.1310T>A | p.Ile437Asn | missense_variant | 10/23 | 1 | NM_005633.4 | ENSP00000384675.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Noonan syndrome 4 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | - | - - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The p.I437N variant (also known as c.1310T>A), located in coding exon 10 of the SOS1 gene, results from a T to A substitution at nucleotide position 1310. The isoleucine at codon 437 is replaced by asparagine, an amino acid with dissimilar properties, and is located in the pleckstrin homology domain. This alteration has been reported in two individuals with Noonan syndrome, including as a de novo occurrence in one case (Lepri F et al. Hum Mutat, 2011 Jul;32:760-72; Lepri FR et al. BMC Med Genet, 2014 Jan;15:14). Another alteration at the same codon, p.I437T (c.1310T>C), has been detected in several unrelated individuals reported to have Noonan syndrome, including de novo occurrences in affected index cases (Lepri F et al. Hum Mutat, 2011 Jul;32:760-72; Moniez S et al. Eur J Endocrinol, 2018 Dec;179:409-418; Prasad RM et al. Pediatr Blood Cancer, 2018 11;65:e27362; Yang L et al. BMC Med Genet, 2018 12;19:212; Ferriero K et al. Front Pediatr, 2020 Sep;8:515; Lazzaro G et al. Mol Genet Genomic Med, 2020 04;8:e1069). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
RASopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 22, 2020 | This variant has been observed in individual(s) with Noonan syndrome (PMID: 24451042). This sequence change replaces isoleucine with asparagine at codon 437 of the SOS1 protein (p.Ile437Asn). The isoleucine residue is moderately conserved and there is a large physicochemical difference between isoleucine and asparagine. This variant is not present in population databases (ExAC no frequency). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOS1 protein function. This variant disrupts the p.Ile437 amino acid residue in SOS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21387466, 24451042, Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.